|Videos|December 15, 2020

Oral Semaglutide: Cardiovascular Outcomes, Safety, and Tolerability

The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Click PLAY to watch the video abstract.


Click here to watch the full supplement infographic.


Click here to read full article to this video abstract.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo